PNTG
Pennant GroupBNasdaq / Health Care Equipment & Services
Last Price
At close
2026-06-02
Current thesis
Pennant enters 2026 with strong recent operating momentum, explicit EBITDA and EPS guidance, and a broader footprint after 2025 expansion. If integration stays clean and former UnitedHealth/Amedisys assets ramp as planned, earnings power can keep compounding from here.
Posture
Constructive
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite, 7D delta -5.1.
What can break
Acquisition pacing that outruns local operating bandwidth or balance-sheet flexibility
Momentum
78
Value
54
Sentiment
47
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $33.00 · Bull $38.00 · Bear $25.50
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-01 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
As of 2026-04-15 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-06-02
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $37.83
Why
Momentum78 · Δ7d -5.1
Value54 · Δ7d +0.5
Sentiment47 · Δ7d +8.9
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Momentum · See technicals
Momentum
78
34% active weight
Current posture
7d trendSoftening
Δ7d
-5.1
Δ21d
+1.9
Value
54
32% active weight
Current posture
7d trendFlat
Δ7d
+0.5
Δ21d
+1.1
Sentiment
47
33% active weight
Current posture
7d trendImproving
Δ7d
+8.9
Δ21d
+14.1
Why this grade
Composite grade B. Momentum 77.9 / Value 54.0 / Sentiment 47.0
Fundamentals (TTM)As of 2026-06-01
Fundamentals (TTM)
As of 2026-06-01
Market Cap
$1.11B
Beta
1.27
Shares Out
34.59M
P/E (TTM)
37.6
P/S (TTM)
1.16
P/FCF (TTM)
35.28
Rev YoY
+26.8%
EPS YoY
-12.9%
Gross Margin
+20.1%
Op Margin
+5.2%
Net Debt
-$24.25M
Current Ratio
1.04
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology